Bachem Holding AG Bachem Holding AG

Bachem Holding AG

BANB

Pozycja w akcjach #2526
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Cena akcji
$100.24
Kapitalizacja rynkowa
$7.51B
Zmiana (1 dzień)
-1.84%
Zmiana (1 rok)
48.99%
Kraj
CH
Handel Bachem Holding AG (BANB)

Kategoria

Healthcare
Historia ceny akcji dla Bachem Holding AG (BANB)
Najwyższa cena zamknięcia: $105.12 dnia 2026-10-01

Najniższa cena zamknięcia: $13.47 dnia 2001-03-01
Historia cen akcji firmy Bachem Holding AG od 2001 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 26.87%
2025 -3.05%
2024 -5.47%
2023 -16.69%
2022 -35.59%
2021 68.81%
2020 169.92%
2019 28.96%
2018 -16.46%
2017 68.14%
2016 64.94%
2015 3.94%
2014 -8.15%
2013 45.10%
2012 -0.04%
2011 -34.01%
2010 -12.09%
2009 -5.58%
2008 -20.36%
2007 13.73%
2006 32.09%
2005 1.28%
2004 12.61%
2003 11.00%
2002 -19.59%
2001 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$536.13 25.72%
US
$200.12 645.31%
US
$137.83 -3.78%
AU
$291.76 2.51%
BE
$880.01 8.09%
NL